← FDA Drug Approvals (Drugs@FDA)

SEVELAMER CARBONATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MACLEODS PHARMS LTD · Approved 2024-04-25

Drug application

FDA Application #

ANDA207291

Application type

Abbreviated New Drug Application (Generic)

Brand name

SEVELAMER CARBONATE

Generic name

SEVELAMER CARBONATE

Active ingredients

SEVELAMER CARBONATE

Dosage form

FOR SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

MACLEODS PHARMS LTD

Manufacturer

NorthStar RxLLC

First approval

2024-04-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown